Φορτώνει......
Inhibition of plasminogen activator inhibitor-1 is a potential therapeutic strategy in ovarian cancer
Plasminogen activator inhibitor (PAI)-1 is predictive of poor outcome in several types of cancer. The present study investigated the biological role for PAI-1 in ovarian cancer and potential of targeted pharmacotherapeutics. In patients with ovarian cancer, PAI-1 mRNA expression in tumor tissues was...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Cancer Biol Ther |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Taylor & Francis
2015
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4623014/ https://ncbi.nlm.nih.gov/pubmed/25587663 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2014.1001271 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|